Kazia Therapeutics (KZIA) Liabilities and Shareholders Equity (2017 - 2025)

Generated on {Timestamp} © BusinessQuant.com

Generated on {Timestamp} Powered by

Kazia Therapeutics (KZIA) has disclosed Liabilities and Shareholders Equity for 4 consecutive years, with $14.2 million as the latest value for Q2 2024.

• For the quarter ending Q2 2024, Liabilities and Shareholders Equity fell 24.21% year-over-year to $14.2 million, compared with a TTM value of $33.0 million through Jun 2025, down 39.26%, and an annual FY2024 reading of $14.2 million, down 25.15% over the prior year.
• Liabilities and Shareholders Equity was $14.2 million for Q2 2024 at Kazia Therapeutics, down from $18.8 million in the prior quarter.
• Across five years, Liabilities and Shareholders Equity topped out at $18.8 million in Q2 2023 and bottomed at $14.2 million in Q2 2024.

Peer Comparison